Viral Vector Production Platform
Rapid Path to First in Human with greater predictability.
To alleviate the industry bottleneck for Viral Vector Supply, we invested significant resources to develop a production platform that delivers QC tested and released GMP lots.
Viral Vector Production Platform Overview
- Ideal for Lenti, AAV, and Adenovirus Viral Vectors
- Greater Supply Chain Control – materials are in stock, assembled, and released
- Accelerated program start – plug and play if you meet defined criteria
- Elements include raw materials, cell line, MCB/WCB, plasmids, upstream/downstream process, analytics, batch records, SOP’s, trained staff
- Closed Adherent Production System utilizing Corning HyperStacks reduces contamination risks
- Dedicated Suite Model: Upstream and Downstream performed in the same suite
- Up to 250 L Yields (Gene of Interest Vector Dependent)
- Integrated in-process and release testing performed onsite
Request a quote
Speak to our technical team today.
Platform, Hybrid or Custom? Take this quiz to find out if your Gene of Interest is compatible with our platform.
Speak with our experts
Learn more about our platform.